- Home
- ABVC vs LOAN Comparison
ABVC vs LOAN Comparison
Compare ABVC & LOAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABVC
- LOAN
- Stock Information
- Founded
- ABVC 2015
- LOAN 1989
- Country
- ABVC United States
- LOAN United States
- Employees
- ABVC N/A
- LOAN N/A
- Industry
- ABVC Biotechnology: Pharmaceutical Preparations
- LOAN Real Estate Investment Trusts
- Sector
- ABVC Health Care
- LOAN Real Estate
- Exchange
- ABVC Nasdaq
- LOAN Nasdaq
- Market Cap
- ABVC 52.1M
- LOAN 61.5M
- IPO Year
- ABVC N/A
- LOAN 1999
- Fundamental
- Price
- ABVC $2.72
- LOAN $5.45
- Analyst Decision
- ABVC
- LOAN
- Analyst Count
- ABVC 0
- LOAN 0
- Target Price
- ABVC N/A
- LOAN N/A
- AVG Volume (30 Days)
- ABVC 82.8K
- LOAN 21.2K
- Earning Date
- ABVC 11-13-2025
- LOAN 10-22-2025
- Dividend Yield
- ABVC N/A
- LOAN 8.52%
- EPS Growth
- ABVC N/A
- LOAN N/A
- EPS
- ABVC N/A
- LOAN 0.48
- Revenue
- ABVC $391,242.00
- LOAN $7,300,469.00
- Revenue This Year
- ABVC $735.18
- LOAN N/A
- Revenue Next Year
- ABVC N/A
- LOAN $4.47
- P/E Ratio
- ABVC N/A
- LOAN $11.25
- Revenue Growth
- ABVC 186.84
- LOAN N/A
- 52 Week Low
- ABVC $0.40
- LOAN $4.74
- 52 Week High
- ABVC $5.48
- LOAN $6.05
- Technical
- Relative Strength Index (RSI)
- ABVC 45.18
- LOAN 55.94
- Support Level
- ABVC $2.64
- LOAN $5.28
- Resistance Level
- ABVC $2.90
- LOAN $5.44
- Average True Range (ATR)
- ABVC 0.16
- LOAN 0.11
- MACD
- ABVC 0.00
- LOAN 0.01
- Stochastic Oscillator
- ABVC 33.87
- LOAN 98.38
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.
About LOAN Manhattan Bridge Capital Inc
Manhattan Bridge Capital Inc is a real estate finance company taxed as a REIT that specializes in originating, servicing and managing a portfolio of first mortgage loans. The company offers short-term, secured, non-banking loans which may renew or extend, before or after their initial term expires, to real estate investors to fund their acquisition, renovation, rehabilitation or development of residential or commercial properties located in the New York metropolitan area, including New Jersey and Connecticut, and in Florida.